600267 海正藥業
按盤價 
13.110 +1.190 (+9.983%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.052 | 6.381 | 7.312 | -1.152 | 6.356 |
| 總資產報酬率 ROA (%) | 2.465 | 3.486 | 3.580 | -0.512 | 2.563 |
| 投入資產回報率 ROIC (%) | 3.035 | 4.307 | 4.374 | -0.636 | 3.196 | 邊際利潤分析 |
| 銷售毛利率 (%) | 50.868 | 44.834 | 42.456 | 41.542 | 44.222 |
| 營業利潤率 (%) | 20.227 | 8.219 | 6.976 | 0.890 | 5.998 |
| 息稅前利潤/營業總收入 (%) | 20.820 | 8.526 | 8.191 | 1.082 | 8.315 |
| 淨利潤/營業總收入 (%) | 14.999 | 5.190 | 5.719 | -0.965 | 4.317 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 67.742 | 134.778 | 107.212 | -278.042 | 113.401 |
| 價值變動淨收益/利潤總額(%) | 36.241 | -8.767 | 19.849 | -90.002 | -11.155 |
| 營業外收支淨額/利潤總額(%) | -0.222 | -6.336 | -0.454 | 207.936 | 0.138 | 償債能力分析 |
| 流動比率 (X) | 0.997 | 0.928 | 0.922 | 0.966 | 0.899 |
| 速動比率 (X) | 0.688 | 0.638 | 0.630 | 0.669 | 0.630 |
| 資產負債率 (%) | 33.430 | 41.191 | 46.289 | 52.596 | 55.638 |
| 帶息債務/全部投入資本 (%) | 19.628 | 26.893 | 34.150 | 41.745 | 43.843 |
| 股東權益/帶息債務 (%) | 400.729 | 265.322 | 187.257 | 134.380 | 124.129 |
| 股東權益/負債合計 (%) | 193.778 | 138.829 | 112.821 | 87.458 | 77.330 |
| 利息保障倍數 (X) | 32.677 | 10.703 | 6.569 | 0.568 | 3.601 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 47.760 | 60.812 | 64.245 | 78.290 | 71.945 |
| 存貨周轉天數 (天) | 116.567 | 107.670 | 113.488 | 118.569 | 111.653 |
| 備註： | 即時報價更新時間為 07/08/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
